SBIR [Phase 1]: Stabilized Prasugrel Enantiomers for Pediatric Sickle Cell Disease

  • Li, Zhenyu (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date12/7/16 → 5/31/17